🔎 Trials Near Me

Home › Myositis › Texas › Houston

Myositis clinical trials in Houston, TX

5 studies for Myositis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RecruitingPhase 2/3
  • Houston Methodist Hospital - Accepting Adult Patients, Houston
  • University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

RecruitingPhase 2
  • University of Texas - Houston, Houston
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07103746

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

RecruitingPhase 3
  • Nerve & Muscle Center of Texas, Houston
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

RecruitingPhase 1/2
  • Nkarta Investigational Site, Houston
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

RecruitingPhase 2
  • Artiva Investigational Site Bellaire, Bellaire · 7 mi away
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114

About Myositis

Myositis means inflammation of the muscles. Two specific types are polymyositis and dermatomyositis. Read about myositis symptoms and management.

More about Myositis on MedlinePlus

Myositis trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.